` Indriķis Liepa | COBALT

Indriķis Liepa

Partner / Latvia


Indriķis Liepa heads IP, IT and Regulatory practice group and is among the leading practitioners in pharmacy law. He has a vast track record of over 15 years in consulting the leading local and foreign financial, food production, IT and other companies. Indriķis has substantial skills base in arranging major local M&A deals and significant investment projects.

Indriķis has extensive knowledge on pharmacy law and is rendering both – daily legal support to numerous pharmacy undertakings and has also advised on major pharmaceutical industry headline deals.


  • Corporate/Commercial – Band 3, Chambers Global and Europe 2024
  • Leading Trademark Professional – Silver band, World Trademark Review 1000 2024
  • Intellectual Property – Transactions star, IP STARS 2024


  • Latvian, English, Russian

Membership & education

  • Latvian Bar Association (since 2002)
  • Institute for Corporate Sustainability and Responsibility
  • International Association of Young Lawyers
  • Master’s degree in Law, Riga Graduate School of Law, Riga, Latvia (2003)
  • Lawyer’s qualification,  University of Latvia, Riga, Latvia (2002)

    Verification platform Verifeye Online secures investment from New Nordic Ventures

    1242 Apps acquires shares in technology start-up Chili Labs

    Poultry producer Putnu fabrika Ķekava completes its reorganisation and rebrands as Ķekava Foods

    PLAY acquires Latvian technology start-up Veset

    COBALT advised SAMSUNG C&T on investment in Forta PRO

    COBALT advised Syneos Health on acquisition of a leading contract research company

    COBALT advised SuperHero Capital on a EUR 450 000 investment into PrintOnPack.com

    COBALT advised Biogen on launching its operations in Latvia and Estonia

    COBALT advised Pfizer’s Upjohn spin-off on merger with Mylan NV

    COBALT advised capital300 and Chalfen Ventures on a EUR 5 million investment into Lokalise

    COBALT advises AbbVie in acquisition of Allergan

    COBALT advises Roche Latvija on the Acquisition of Medilink distribution business

    COBALT Advises Prezi in Acquiring Data Visualization Company Infogram

    COBALT advised Anttila on different corporate governance matters and management structure

    COBALT advised VAS Valsts nekustamie ipasumi in acquisition of shares in SIA Biroju centrs Ezerparks

    COBALT represents Konekesko Latvija in tax dispute with the State Revenue Service

    Tax advice to Octapharma Nordic AB

    COBALT represents Tavex, the largest investment gold dealer in Northern Europe

    Representation of Abbott Laboratories Baltics

    COBALT advises H&M on Latvian tax matters

    General legal assistance to Mylan

    Legal assistance to Nordic Sugar AS

    General legal assistance to GlaxoSmithKline

    COBALT advises Abbott Laboratories on sale to Mylan of non-U.S. developed markets specialty and branded generics business

    General legal assistance to Roche

    COBALT advises Association of Biopharmaceutical Medicinal Products in Latvia (includes AbbVie, Merck Serono, Roche and others) on amendments to legal pharma-regulations

    General legal assistance to Abbott Laboratories

    General legal assistance to Abbvie

    COBALT advises Franklin Templeton Investments in acquisition of majority stake in SIA Storent Holding

    COBALT advises Merck & Co., Inc in sale of Merck’s consumer care business

    COBALT represents minority shareholder interests in acquisition of 60% stake in Ask.fm by Dutch company IAC Search Europe B.V.

    Legal advice to Roche Latvia on implementation of a distribution scheme

    COBALT provides legal assistance to SIA FMS on company sale to major North European IT company Visma Group

    COBALT advises Wikimedia on Latvian tax matters

    Tax advice to Homburg Invest Inc. in global corporate restructuring process

    COBALT advises Canadian stock listed company within implementation of a restructuring plan governed under Canadian CCAA rules in the Baltics

    COBALT advises Association for Lymphoma Patients’ Support and the Rare Disease Association Caladrius

    We are driven by your recognition

    Indriķis Liepa advises clients on M&A transactions and setting up joint ventures. He is particularly active in the pharmaceutical sector.
    Chambers Europe 2023, Corporate / Commercial
    Indrikis Liepa has a clear vision, the ability to explain legal issues in business language and good project management skills. He is flexible and responsive.
    Legal 500 2020, Commercial, Corporate and M&A